Home › Funds › Millennium Management › AVBP
Millennium Management position in AVBP
ARRIVENT BIOPHARMA INC · Health Care
Latest position (Q2 2026)438.66K sh
Reported value held$15.24M
Portfolio Weight0.01%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 211.69K | $3.78M | New |
| Q2 2024 | 12.10K | $224.51K | Reduce |
| Q3 2024 | 216.63K | $5.09M | Add |
| Q4 2024 | 52.55K | $1.40M | Reduce |
| Q1 2025 | 158.06K | $2.92M | Add |
| Q2 2025 | 176.17K | $3.84M | Add |
| Q3 2025 | 286.10K | $5.28M | Add |
| Q4 2025 | 281.95K | $5.67M | Reduce |
| Q1 2026 | 425.92K | $9.83M | Add |
| Q2 2026 | 438.66K | $15.24M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVBP
- Hillhouse Capital (HHLR Advisors) 3.93M sh · $136.50M · Q2 2026
- BlackRock Inc 3.25M sh · $112.92M · Q2 2026
- Fidelity Management & Research (FMR) 2.78M sh · $96.54M · Q2 2026
- Vanguard Group 1.87M sh · $37.61M · Q4 2025
- Geode Capital Management 972.63K sh · $33.80M · Q2 2026
- D. E. Shaw & Co 872.01K sh · $30.29M · Q2 2026
- Goldman Sachs Group 853.72K sh · $29.66M · Q2 2026
- Point72 Asset Management 566.80K sh · $19.69M · Q2 2026
- UBS Group AG 438.59K sh · $15.24M · Q2 2026
- Balyasny Asset Management 395.45K sh · $13.74M · Q2 2026
- Northern Trust Corp 332.75K sh · $11.56M · Q2 2026